• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成及苯并咪唑杂合体作为α-葡萄糖苷酶抑制剂的分子对接研究。

Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.

机构信息

Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D.E., Malaysia; Faculty of Applied Science, UiTM Shah Alam, 40450 Shah Alam, Selangor D.E., Malaysia.

Atta-ur-Rahman Institute for Natural Product Discovery, Universiti Teknologi MARA (UiTM), Puncak Alam Campus, 42300 Bandar Puncak Alam, Selangor D.E., Malaysia; Faculty of Applied Science, UiTM Shah Alam, 40450 Shah Alam, Selangor D.E., Malaysia.

出版信息

Bioorg Chem. 2017 Feb;70:184-191. doi: 10.1016/j.bioorg.2016.12.009. Epub 2016 Dec 26.

DOI:10.1016/j.bioorg.2016.12.009
PMID:28043716
Abstract

Thiourea derivatives having benzimidazole 1-17 have been synthesized, characterized by H NMR, C NMR and EI-MS and evaluated for α-glucosidase inhibition. Identification of potential α-glucosidase inhibitors were done by in vitro screening of 17 thiourea bearing benzimidazole derivatives using Baker's yeast α-glucosidase enzyme. Compounds 1-17 exhibited a varying degree of α-glucosidase inhibitory activity with IC values between 35.83±0.66 and 297.99±1.20μM which are more better than the standard acarbose (IC=774.5±1.94μM). Compound 10 and 14 showed significant inhibitory effects with IC value 50.57±0.81 and 35.83±0.66μM, respectively better than the rest of the series. Structure activity relationships were established. Molecular docking studies were performed to understand the binding interaction of the compounds.

摘要

合成了具有苯并咪唑 1-17 的硫脲衍生物,通过 H NMR、C NMR 和 EI-MS 进行了表征,并评估了它们对α-葡萄糖苷酶的抑制作用。通过使用贝克氏酵母α-葡萄糖苷酶对 17 个含有苯并咪唑的硫脲衍生物进行体外筛选,确定了潜在的α-葡萄糖苷酶抑制剂。化合物 1-17 表现出不同程度的α-葡萄糖苷酶抑制活性,IC 值在 35.83±0.66 和 297.99±1.20μM 之间,优于标准阿卡波糖(IC=774.5±1.94μM)。化合物 10 和 14 表现出显著的抑制作用,IC 值分别为 50.57±0.81 和 35.83±0.66μM,优于其他化合物。建立了构效关系。进行了分子对接研究,以了解化合物的结合相互作用。

相似文献

1
Synthesis, molecular docking studies of hybrid benzimidazole as α-glucosidase inhibitor.合成及苯并咪唑杂合体作为α-葡萄糖苷酶抑制剂的分子对接研究。
Bioorg Chem. 2017 Feb;70:184-191. doi: 10.1016/j.bioorg.2016.12.009. Epub 2016 Dec 26.
2
Synthesis, in vitro evaluation and molecular docking studies of biscoumarin thiourea as a new inhibitor of α-glucosidases.合成、体外评价及 biscoumarin 硫脲作为新型 α-葡萄糖苷酶抑制剂的分子对接研究。
Bioorg Chem. 2015 Dec;63:36-44. doi: 10.1016/j.bioorg.2015.09.004. Epub 2015 Sep 25.
3
Benzimidazole derivatives as new α-glucosidase inhibitors and in silico studies.苯并咪唑衍生物作为新型的α-葡萄糖苷酶抑制剂及计算机模拟研究。
Bioorg Chem. 2016 Feb;64:29-36. doi: 10.1016/j.bioorg.2015.11.006. Epub 2015 Nov 23.
4
Novel pyridine-2,4,6-tricarbohydrazide thiourea compounds as small key organic molecules for the potential treatment of type-2 diabetes mellitus: In vitro studies against yeast α- and β-glucosidase and in silico molecular modeling.新型吡啶-2,4,6-三羧酸双缩胍硫脲类化合物作为潜在的 2 型糖尿病治疗的小分子有机药物:体外研究对酵母 α-和 β-葡萄糖苷酶的抑制作用及计算机模拟分子建模。
Arch Pharm (Weinheim). 2018 Jan;351(1). doi: 10.1002/ardp.201700236. Epub 2017 Dec 1.
5
Synthesis, α-glucosidase inhibitory, cytotoxicity and docking studies of 2-aryl-7-methylbenzimidazoles.2-芳基-7-甲基苯并咪唑的合成、α-葡萄糖苷酶抑制活性、细胞毒性及对接研究
Bioorg Chem. 2016 Apr;65:100-9. doi: 10.1016/j.bioorg.2016.02.004. Epub 2016 Feb 13.
6
Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.香豆素类衍生物的合成、α-葡萄糖苷酶抑制活性及分子对接研究。
Bioorg Chem. 2018 Apr;77:586-592. doi: 10.1016/j.bioorg.2018.01.033. Epub 2018 Feb 17.
7
Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors.新型苯并咪唑-1,2,3-三唑杂合体的合成及生物评价作为潜在的α-葡萄糖苷酶抑制剂。
Bioorg Chem. 2020 Jan;95:103482. doi: 10.1016/j.bioorg.2019.103482. Epub 2019 Dec 4.
8
Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of α-glucosidase.噻唑衍生物作为新型α-葡萄糖苷酶抑制剂的合成、体外评价及分子对接研究
Bioorg Chem. 2015 Oct;62:15-21. doi: 10.1016/j.bioorg.2015.06.006. Epub 2015 Jun 29.
9
Synthesis, in vitro alpha-glucosidase inhibitory potential of benzimidazole bearing bis-Schiff bases and their molecular docking study.合成、体外α-葡萄糖苷酶抑制活性的苯并咪唑二席夫碱及其分子对接研究。
Bioorg Chem. 2020 Jan;94:103394. doi: 10.1016/j.bioorg.2019.103394. Epub 2019 Oct 23.
10
Synthesis of Novel Triazinoindole-Based Thiourea Hybrid: A Study on α-Glucosidase Inhibitors and Their Molecular Docking.新型三嗪并吲哚基硫脲杂合体的合成:α-葡萄糖苷酶抑制剂及其分子对接研究。
Molecules. 2019 Oct 23;24(21):3819. doi: 10.3390/molecules24213819.

引用本文的文献

1
Novel Benzimidazole-Endowed Chalcones as α-Glucosidase and α-Amylase Inhibitors: An Insight into Structural and Computational Studies.新型苯并咪唑取代查尔酮作为α-葡萄糖苷酶和α-淀粉酶抑制剂:结构与计算研究洞察
Molecules. 2024 Nov 27;29(23):5599. doi: 10.3390/molecules29235599.
2
Design, synthesis, and evaluation of novel substituted imidazo[1,2-c]quinazoline derivatives as potential α-glucosidase inhibitors with bioactivity and molecular docking insights.新型取代咪唑并[1,2-c]喹唑啉衍生物的设计、合成与评价作为潜在的α-葡萄糖苷酶抑制剂的生物活性和分子对接研究。
Sci Rep. 2024 Nov 11;14(1):27507. doi: 10.1038/s41598-024-78878-2.
3
Potent α-glucosidase inhibitors with benzimidazole-propionitrile hybridization; synthesis, bioassay and docking study.
具有苯并咪唑-丙腈杂化结构的强效α-葡萄糖苷酶抑制剂;合成、生物活性测定及对接研究。
Future Med Chem. 2024;16(22):2395-2410. doi: 10.1080/17568919.2024.2401314. Epub 2024 Oct 11.
4
Targeting Diabetes with Azole-derived Medicinal Agents.用唑类药物靶向治疗糖尿病。
Med Chem. 2024;20(9):855-875. doi: 10.2174/0115734064289990240524055002.
5
Benzimidazole as a Privileged Scaffold in Drug Design and Discovery.苯并咪唑作为药物设计和发现中的优势骨架。
Curr Top Med Chem. 2024;24(17):1504-1528. doi: 10.2174/0115680266314704240522112439.
6
Unlocking the Pharmacological Potential of Benzimidazole Derivatives: A Pathway to Drug Development.解锁苯并咪唑衍生物的药理潜力:药物开发之路。
Curr Top Med Chem. 2024;24(5):437-485. doi: 10.2174/0115680266283641240109080047.
7
A Review on the Development of Novel Heterocycles as α-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus.新型杂环类 α-葡萄糖苷酶抑制剂用于治疗 2 型糖尿病的研究进展综述。
Med Chem. 2024;20(5):503-536. doi: 10.2174/0115734064264591231031065639.
8
Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies.咪唑并[1,2-c]喹唑啉类作为新型强效α-葡萄糖苷酶抑制剂:设计、合成、生物评价和计算机模拟研究。
Sci Rep. 2023 Sep 21;13(1):15672. doi: 10.1038/s41598-023-42549-5.
9
Design, synthesis, in vitro, and in silico evaluations of benzo[d]imidazole-amide-1,2,3-triazole-N-arylacetamide hybrids as new antidiabetic agents targeting α-glucosidase.苯并[d]咪唑酰胺-1,2,3-三唑-N-芳基乙酰胺杂合体的设计、合成、体外和计算机评估作为新型抗糖尿病药物靶向α-葡萄糖苷酶。
Sci Rep. 2023 Jul 31;13(1):12397. doi: 10.1038/s41598-023-39424-8.
10
Discovery of novel flavonoid derivatives as potential dual inhibitors against α-glucosidase and α-amylase: virtual screening, synthesis, and biological evaluation.发现新型黄酮类衍生物作为潜在的α-葡萄糖苷酶和α-淀粉酶双重抑制剂:虚拟筛选、合成与生物学评价。
Mol Divers. 2024 Jun;28(3):1629-1650. doi: 10.1007/s11030-023-10680-0. Epub 2023 Jun 27.